With research laboratories around the world racing to develop a coronavirus vaccine, a unique challenge has emerged: how to balance intellectual property rights with serving the public good.
May 29, 2020
0
4
Every major medical center in America sits on a gold mine. The data they hold about their patients and research participants could be worth millions of dollars to companies that would explore it for clues that could lead ...
May 28, 2020
0
5
It's almost certain that COVID-19 cases across the nation have been vastly undercounted, since people with few to no symptoms—who may be infected but have immunity—are rarely tested.
May 15, 2020
0
2
In the fight against the current pandemic, researchers of the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg are coordinating an international collaboration to build a COVID-19 Disease Map: ...
May 13, 2020
0
0
Dr. Enzo De Sena and Dr. Milton Mermikides at the University of Surrey have set up the COVID-19 Listening Project, which is dedicated to the sonic and musical representation of COVID-19 data. A 42-minute choral piece and ...
May 6, 2020
0
3
Dr. Nader Pouratian implanted matchbook-sized devices into the brains of four blind volunteers more than two years ago.
Apr 30, 2020
0
1
A new on-site nucleic acid detection system for quick identification of the SARS-CoV-2 that causes COVID-19 was recently developed by a research team at the Suzhou Institute of Biomedical Engineering and Technology (SIBET) ...
Apr 24, 2020
0
0
Despite COVID-19-related lockdowns, face-to-face eye examinations continue to be a necessity for many—a situation that has forced doctors and engineers at the University of Michigan to get creative.
Apr 2, 2020
0
2
LMU virologist Gerd Sutter talks about the complex task of developing a vaccine against the new coronavirus—and the approach he has adopted, which is already being tested against the related coronavirus MERS.
Mar 30, 2020
0
2
The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced ...
Mar 26, 2020
0
5
